Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 214,326 | 161,628 | 108,845 | 56,737 | 163,889 |
| Depreciation Amortization | 37,873 | 28,336 | 18,920 | 9,460 | 37,774 |
| Income taxes - deferred | -6,849 | -2,338 | -4,755 | -2,321 | -9,388 |
| Accounts receivable | -61,001 | -40,933 | -387 | -5,789 | -11,962 |
| Accounts payable and accrued liabilities | -5,391 | -7,497 | -11,065 | -5,396 | 1,798 |
| Other Working Capital | -60,895 | -45,728 | -6,105 | -7,051 | 30,914 |
| Other Operating Activity | 90,607 | 70,311 | 25,888 | 14,403 | 26,783 |
| Operating Cash Flow | $208,670 | $163,779 | $131,341 | $60,043 | $239,808 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | -26 | -26 | N/A | -556 |
| Investing Cash Flow | $-58 | $-26 | $-26 | $0 | $-556 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,669 | 12,793 | 6,997 | 4,787 | 154,515 |
| Common Stock Repurchased | -25,300 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -6,363 | -4,207 | -3,065 | -1,727 | -13,850 |
| Financing Cash Flow | $-16,994 | $8,586 | $3,932 | $3,060 | $140,665 |
| Beginning Cash Position | 517,553 | 517,553 | 517,553 | 517,553 | 137,636 |
| End Cash Position | 709,171 | 689,892 | 652,800 | 580,656 | 517,553 |
| Net Cash Flow | $191,618 | $172,339 | $135,247 | $63,103 | $379,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | 208,670 | 163,779 | 131,341 | 60,043 | 239,808 |
| Capital Expenditure | -58 | -26 | -26 | 0 | -556 |
| Free Cash Flow | 208,612 | 163,753 | 131,315 | 60,043 | 239,252 |